Repeated immune activation with low-dose lipopolysaccharide attenuates the severity of Huntington's disease in R6/2 transgenic mice

DOI: 10.1080/19768354.2018.1473291

Keywords: Huntington’s disease, R6/2 transgenic mice, lipopolysaccharide, Dendritic cells, macrophages

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text